1 PCV13 is recommended for all children younger than 5 years old, all adults 65 years or older, and people 6 years or older with certain risk factors. 2  PPSV is recommended for all adults who are 65 years or older and for people 2 through 64 years old who are at high risk for pneumococcal disease. 1 The number of doses recommended and the intervals between doses will depend on the child's age when vaccination begins. 2  Ask your healthcare provider for details. 3  Children 2 through 5 Years Old. 4  Healthy children 24 months through 4 years old who are unvaccinated or have not completed the PCV13 series should get 1 dose.
If the patient is 65 years and older who has received PPSV23 vaccine, PCV13 should be given at least 12 months later. A second dose of PPSV23 should be given 6-12 months after the PCV13 dose and 5 years after the most recent PPSV23 dose. The pneumonia vaccine is available at: Healthcare Clinic for patients aged 65+, ages 19-64 who smoke or have asthma, ages 7+ with long-term health conditions. Walgreens Pharmacy. Ages vary by state.
Vaccine Information. The pneumococcal conjugate vaccine, PCV13 or Prevnar 13®, is currently recommended for all children younger than 5 years old, all adults 65 years or older, and people 6 through 64 years old with certain medical conditions. At a Glance. Pneumococcal conjugate vaccine (PCV13) is recommended for all children younger than 5 years old, all adults 65 years or older, and people 6 years or older with certain risk factors. Pneumococcal polysaccharide vaccine (PPSV23) is recommended for all adults 65 years or older
The two vaccines should not be given at the same visit. In addition to adults age 65 years and older, adults age 19 through 64 years who have the conditions specified below and who have not previously received PCV13 should receive a PCV13 dose during their next vaccination opportunity. All children with risk factors for pneumococcal disease or its complications should be vaccinated with PPSV23 beginning at age 2 years. If they are age-eligible and are due for a dose of PCV13, give that one first and then wait 8 weeks before giving PPSV23.
1 Adults 19 years or older with one of the above listed conditions who have not received any pneumococcal vaccine, should get a dose of PCV13 first and should also continue to receive the recommended doses of PPSV23. 2  Ask your healthcare provider for details. 1 The number of doses recommended and the intervals between doses will depend on the child's age when vaccination begins. 2  Ask your healthcare provider for details. 3  Children 2 through 5 Years Old. 4  Healthy children 24 months through 4 years old who are unvaccinated or have not completed the PCV13 series should get 1 dose.
Vaccination is the best way to prevent pneumococcal infection. Pneumococcal Vaccine Schedule. Children should receive 4 doses of PCV13. The first dose should be given at 2 months, the second dose at 4 months, the third dose at 6 months, and the fourth dose at 12-15 months. Adults age 65 years and older should receive the two types of pneumococcal vaccines (PCV13 and PPSV23). You should receive a dose of PCV13 first, followed by a dose of the PPSV23, ideally 6 to 12 months later
There are currently 2 types of pneumococcal vaccines: pneumococcal conjugate vaccine (PCV13 or Prevnar 13®) and pneumococcal polysaccharide vaccine (PPSV23 or Pneumovax®). 1  PCV13 is recommended for all children younger than 5 years old, all adults 65 years or older, and people 6 years or older with certain risk factors. 1 The number of doses recommended and the intervals between doses will depend on the child's age when vaccination begins. 2  Ask your healthcare provider for details. 3  Children 2 through 5 Years Old. 4  Healthy children 24 months through 4 years old who are unvaccinated or have not completed the PCV13 series should get 1 dose.
According to the ACIP recommendations published in September 2014, both pneumococcal conjugate vaccine (PCV13, Prevnar 13, Pfizer) and pneumococcal polysaccharide vaccine (PPSV23, Pneumovax, Merck) should be administered routinely in a series to all adults age 65 years and older. All children with risk factors for pneumococcal disease or its complications should be vaccinated with PPSV23 beginning at age 2 years. If they are age-eligible and are due for a dose of PCV13, give that one first and then wait 8 weeks before giving PPSV23.
The pneumococcal conjugate vaccine (PCV13) is recommended for the following adults: 1  Adults ages 19 and older with asplenia, sickle cell disease, cerebrospinal fluid leaks, cochlear implants, or conditions that cause weakening of the immune system. There are two different types of pneumococcal vaccine. One that protects adults against 23 strains of Streptococcus pneumonia bacteria is called pneumococcal polysaccharide vaccine (PPSV23), and it is marketed under the brand name Pneumovax. PPSV23 is made using dead bacteria. The dead germs cannot make you sick.